Parsec Financial Management, Inc. Bristol Myers Squibb CO Transaction History

Parsec Financial Management, Inc.

$2.37 Billion
Q1 2023

A detailed history of Parsec Financial Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 187,426 shares of BMY stock, worth $9.13 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

187,426

Previous 209,943 10.73%

Holding current value

$9.13 Million

Previous $15.1 Million 13.99%

% of portfolio

0.55%

Previous 0.67%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	SELL	$65.71 - $74.53 $1.48 Million - $1.68 Million	-22,517 Reduced 10.73%	187,426 $13 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $280,220 - $331,820	4,092 Added 1.99%	209,943 $15.1 Million
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $3,681 - $2.18 Million	28,322 Added 15.95%	205,851 $14.6 Million
Q2 2022 Jul 06, 2022	BUY	$72.62 - $79.98 $986,833 - $1.09 Million	13,589 Added 8.29%	177,529 $13.7 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $2.61 Million - $3.13 Million	42,446 Added 34.94%	163,940 $12 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $343,071 - $399,940	6,397 Added 5.56%	121,494 $7.58 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $2.5 Million - $2.93 Million	42,276 Added 58.05%	115,097 $6.84 Million
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $1.55 Million - $1.68 Million	24,989 Added 52.24%	72,821 $4.87 Million
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $2.4 Million - $2.7 Million	40,444 Added 547.43%	47,832 $3.02 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $142,502 - $161,481	2,468 Added 50.16%	7,388 $458,000
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $52,318 - $57,976	911 Added 22.72%	4,920 $297,000
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $1,096 - $1,281	-20 Reduced 0.5%	4,009 $236,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $29,371 - $42,683	633 Added 18.64%	4,029 $225,000
Q4 2019 Jan 29, 2020	SELL	$49.21 - $64.19 $29,526 - $38,514	-600 Reduced 15.02%	3,396 $218,000
Q3 2019 Oct 23, 2019	BUY	$42.77 - $50.71 $170,908 - $202,637	3,996 New	3,996 $203,000
Q2 2019 Jul 23, 2019	SELL	$44.62 - $49.34 $187,270 - $207,079	-4,197 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $213,011 - $253,989	-4,721 Reduced 52.94%	4,197 $200,000
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $3,218 - $4,173	-66 Reduced 0.73%	8,918 $464,000
Q3 2018 Oct 30, 2018	BUY	$55.19 - $62.25 $24,338 - $27,452	441 Added 5.16%	8,984 $558,000
Q2 2018 Jul 26, 2018	BUY	$50.53 - $62.98 $59,019 - $73,560	1,168 Added 15.84%	8,543 $473,000
Q4 2017 Jan 26, 2018	BUY	$59.94 - $65.35 $19,540 - $21,304	326 Added 4.62%	7,375 $452,000
Q3 2017 Oct 25, 2017	BUY	$55.23 - $63.74 $389,316 - $449,303	7,049	7,049 $449,000

Others Institutions Holding BMY

# of Institutions

2,399

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.

Account

Parsec Financial Management, Inc. Bristol Myers Squibb CO Transaction History